ÔªøProtection of Corticospinal Tract Neurons	1
ÔªøProtection	1
Corticospinal Tract Neurons	18
Dorsal	52
Spinal Cord Transection and Engraftment of Olfactory Ensheathing Cells MASANORI SASAKI ,1,2 BRYAN C. HAINS ,1,2 KAREN L. LANKFORD ,1,2 STEPHEN G. WAXMAN ,1,2 AND JEFFERY D. KOCSIS1 ,2 * 1Department of Neurology and Center for Neuroscience and Regeneration Research , Yale University School of Medicine , New Haven , Connecticut 2Rehabilitation Research Center , VA Medical Center , West Haven , Connecticut ABSTRACT Transplantation of olfactory ensheathing cells -LRB- OECs -RRB- into the damaged rat spinal cord	59
Spinal Cord Transection and Engraftment of Olfactory Ensheathing Cells MASANORI SASAKI ,1,2 BRYAN C. HAINS ,1,2 KAREN L. LANKFORD ,1,2 STEPHEN G. WAXMAN ,1,2 AND JEFFERY D. KOCSIS1 ,2 * 1Department of Neurology and Center for Neuroscience and Regeneration Research , Yale University School of Medicine , New Haven , Connecticut 2Rehabilitation Research Center , VA Medical Center , West Haven , Connecticut ABSTRACT Transplantation of olfactory ensheathing cells	59
Spinal Cord Transection and Engraftment	59
Olfactory Ensheathing Cells MASANORI SASAKI ,1,2 BRYAN C. HAINS ,1,2 KAREN L. LANKFORD ,1,2 STEPHEN G. WAXMAN ,1,2 AND JEFFERY D. KOCSIS1 ,2 * 1Department of Neurology and Center for Neuroscience and Regeneration Research , Yale University School of Medicine , New Haven , Connecticut 2Rehabilitation Research Center , VA Medical Center , West Haven , Connecticut ABSTRACT Transplantation of olfactory ensheathing cells	102
Ensheathing Cells	112
,1,2 AND JEFFERY D. KOCSIS1 ,2 * 1Department of Neurology and Center for Neuroscience	211
,1,2 AND	211
JEFFERY D. KOCSIS1 ,2 * 1Department of Neurology and Center	220
JEFFERY D. KOCSIS1 ,2	220
1Department of Neurology and Center	242
1Department	242
Neurology and Center	257
Neuroscience	282
Regeneration Research , Yale University School of Medicine , New Haven , Connecticut 2Rehabilitation Research Center , VA Medical Center , West Haven , Connecticut ABSTRACT Transplantation	299
Regeneration Research	299
Yale University School of Medicine	322
New Haven	358
Connecticut 2Rehabilitation Research Center	369
VA Medical Center	414
West Haven	433
Connecticut ABSTRACT Transplantation	445
olfactory ensheathing	486
OECs	515
the damaged rat spinal cord	526
elongative axonal regeneration	572
functional outcome	616
OECs	636
a number of neurotrophic molecules	662
a number	662
neurotrophic molecules	674
the possibility	709
OECs	730
injured corticospinal tract -LRB- CST -RRB- neurons	759
we	802
OECs	818
the dorsal transected spinal cord -LRB- T9 -RRB- and examined primary motor cortex -LRB- M1 -RRB- to assess apoptosis and neuronal loss at 1 and 4 weeks post-transplantation	828
the dorsal	828
spinal cord -LRB- T9 -RRB-	850
spinal cord	850
T9	863
primary motor cortex -LRB- M1 -RRB-	880
primary motor cortex	880
M1	902
apoptosis and neuronal loss at 1 and 4 weeks	916
apoptosis	916
neuronal loss at 1 and 4 weeks	930
neuronal loss	930
at 1 and 4 weeks	944
The number of apoptotic cortical neurons	983
The number	983
apoptotic cortical neurons	997
1	1039
week	1041
the extent of neuronal loss	1051
the extent	1051
neuronal loss	1065
4 weeks	1094
Biochemical analysis	1103
an increase	1134
BDNF levels in the spinal cord injury zone	1149
BDNF levels	1149
the spinal cord injury zone	1164
OEC transplantation at 1	1198
OEC transplantation	1198
1	1221
week	1223
The transplanted OECs	1229
axons at 4 weeks	1282
axons	1282
4 weeks	1291
OEC transplantation into the injured spinal cord	1306
OEC transplantation	1306
the injured spinal cord	1331
distant neuroprotective effects on descending cortical projection neurons	1359
distant neuroprotective effects	1359
cortical projection neurons	1405
INTRODUCTION Disruption of long axonal tracts in the spinal cord	1435
INTRODUCTION Disruption	1435
long axonal tracts in the spinal cord	1462
long axonal tracts	1462
the spinal cord	1484
motor and sensory impairment	1511
motor	1511
sensory impairment	1521
the level of the lesion	1546
the level	1546
the lesion	1559
A number of studies -LRB- Li et al. , 1997 , 1998 ; Ramon-Cueto et al. , 1998 , 2000 ; Imaizumi et al. , 2000 ; Polentes et al. , 2004 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005 ; Ruitenberg et al. , 2005 -RRB-	1571
A number	1571
studies -LRB- Li et al. , 1997 , 1998 ; Ramon-Cueto et al. , 1998 , 2000 ; Imaizumi et al. , 2000 ; Polentes et al. , 2004 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005 ; Ruitenberg et al. , 2005 -RRB-	1583
studies	1583
Li	1592
et al. , 1997 , 1998 ; Ramon-Cueto et al. , 1998 , 2000 ; Imaizumi et al. , 2000 ; Polentes et al. , 2004 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005 ; Ruitenberg et al. , 2005	1595
et al.	1595
1997 , 1998 ; Ramon-Cueto et al. , 1998 , 2000 ; Imaizumi et al. , 2000 ; Polentes et al. , 2004 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005 ; Ruitenberg et al.	1603
1997 , 1998	1603
1997	1603
1998	1609
Ramon-Cueto et al. , 1998 , 2000	1615
Ramon-Cueto	1615
et al. , 1998 , 2000	1627
et al.	1627
1998	1635
2000	1641
Imaizumi et al. , 2000	1647
Imaizumi	1647
et al. , 2000	1656
et al.	1656
2000	1664
Polentes et al. , 2004	1670
Polentes	1670
et al. , 2004	1679
et al.	1679
2004	1687
Sasaki et al. , 2004	1693
Sasaki	1693
et al. , 2004	1700
et al.	1700
2004	1708
Garcia-Alias et al. , 2005	1714
Garcia-Alias	1714
et al. , 2005	1727
et al.	1727
2005	1735
Ruitenberg et al.	1741
Ruitenberg	1741
et al.	1752
2005	1760
structural and functional repair of the spinal cord	1789
structural and functional repair	1789
the spinal cord	1825
transplantation of olfactory ensheathing cells -LRB- OECs -RRB- obtained from the olfactory bulb	1854
transplantation	1854
olfactory ensheathing cells -LRB- OECs -RRB- obtained from the olfactory bulb	1873
olfactory ensheathing cells	1873
OECs	1902
the olfactory bulb	1922
Clinical investigations for SCI using OEC engraftment	1942
Clinical investigations	1942
SCI using OEC engraftment	1970
SCI	1970
OEC engraftment	1980
progress -LRB- Senior , 2002 ; Huang et al. , 2003 ; see Reier , 2004 , for overview of cell-based therapies in SCI -RRB-	2003
progress	2003
Senior , 2002 ; Huang et al. , 2003 ; see Reier , 2004 , for overview of cell-based therapies in SCI	2013
Senior	2013
2002 ; Huang et al. , 2003 ; see Reier , 2004 , for overview of cell-based therapies in SCI	2021
2002	2021
Huang et al. , 2003 ; see Reier , 2004 , for overview of cell-based therapies in SCI	2027
Huang et al. , 2003	2027
Huang	2027
et al. , 2003	2033
et al.	2033
2003	2041
see Reier , 2004 , for overview of cell-based therapies in SCI	2047
Reier , 2004 , for overview	2051
Reier , 2004 ,	2051
Reier	2051
2004	2058
overview	2068
cell-based therapies in SCI	2080
cell-based therapies	2080
SCI	2104
there	2119
considerable evidence suggesting that , under appropriate cell preparation and transplantation conditions , functional outcome in experimental SCI can be enhanced by OEC transplantation	2128
considerable evidence	2128
appropriate cell preparation and transplantation conditions	2173
functional outcome in experimental SCI	2234
functional outcome	2234
experimental SCI	2256
OEC transplantation	2292
questions	2313
regard	2341
cellular mechanisms responsible for improvement in functional outcome	2351
cellular mechanisms	2351
improvement in functional outcome	2387
improvement	2387
functional outcome	2402
spinal mechanisms	2432
long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB- , axonal sparing and neuroprotection -LRB- Plant et al. , 2003 -RRB- , sprouting and plasticity associated with novel polysynaptic pathways -LRB- Keyvan-Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB- , recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- , and remyelination -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004 -RRB-	2458
long tract regeneration	2458
Li	2483
et al. , 1997 ; Ramon-Cueto et al. , 2000	2486
et al.	2486
1997 ; Ramon-Cueto et al.	2494
1997	2494
Ramon-Cueto et al.	2500
Ramon-Cueto	2500
et al.	2512
2000	2520
axonal sparing and neuroprotection -LRB- Plant et al. , 2003 -RRB- , sprouting and plasticity associated with novel polysynaptic pathways -LRB- Keyvan-Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB- , recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- , and remyelination -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004 -RRB-	2527
axonal sparing and neuroprotection -LRB- Plant et al. , 2003 -RRB- , sprouting	2527
axonal sparing and neuroprotection	2527
Plant	2563
et al. , 2003	2569
et al.	2569
2003	2577
plasticity associated with novel polysynaptic pathways -LRB- Keyvan-Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB- , recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- , and remyelination -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004 -RRB-	2598
plasticity	2598
novel polysynaptic pathways -LRB- Keyvan-Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB- , recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- , and remyelination -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004 -RRB-	2625
novel polysynaptic pathways -LRB- Keyvan-Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB-	2625
novel polysynaptic pathways	2625
Keyvan-Fouladi	2654
et al. , 2002 ; Bareyre et al. , 2004	2669
et al.	2669
2002 ; Bareyre et al.	2677
2002	2677
Bareyre et al.	2683
Bareyre	2683
et al.	2691
2004	2699
recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB-	2706
recruitment	2706
endogenous Schwann cells	2721
Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004	2747
Takami	2747
et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004	2754
et al. , 2002	2754
et al.	2754
2002	2762
Boyd et al. , 2004	2768
Boyd	2768
et al. , 2004	2773
et al.	2773
2004	2781
Ramer et al. , 2004	2787
Ramer	2787
et al. , 2004	2793
et al.	2793
2004	2801
remyelination -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004 -RRB-	2812
remyelination	2812
Franklin et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004	2827
Franklin	2827
et al. , 1996 ; Imaizumi et al. , 2000 ; Sasaki et al. , 2004	2836
et al. , 1996	2836
et al.	2836
1996	2844
Imaizumi et al. , 2000	2850
Imaizumi	2850
et al. , 2000	2859
et al.	2859
2000	2867
Sasaki et al. , 2004	2873
Sasaki	2873
et al. , 2004	2880
et al.	2880
2004	2888
A recent study	2895
primary motor cortex -LRB- M1 -RRB- pyramidal neurons	2928
primary motor cortex -LRB- M1 -RRB-	2928
pyramidal neurons	2954
apoptotic cell death	2980
SCI -LRB- Hains et al. , 2003 -RRB-	3019
SCI	3019
Hains	3024
et al. , 2003	3030
et al.	3030
2003	3038
earlier work	3055
corticospinal neurons	3083
spinal cord transection -LRB- McBride et al. , 1989 -RRB-	3127
spinal cord transection	3127
McBride	3152
et al. , 1989	3160
et al.	3160
1989	3168
the present work	3178
we	3196
the supraspinal effects of OEC transplantation on apoptosis and cell survival of corticospinal tract -LRB- CST -RRB- neurons within the M1 cortex	3208
the supraspinal effects	3208
OEC transplantation on apoptosis and cell survival of corticospinal tract -LRB- CST -RRB- neurons within the M1 cortex	3235
OEC transplantation	3235
apoptosis and cell survival of corticospinal tract -LRB- CST -RRB- neurons within the M1 cortex	3258
apoptosis and cell survival	3258
corticospinal tract -LRB- CST -RRB- neurons within the M1 cortex	3289
corticospinal tract -LRB- CST -RRB- neurons	3289
CST	3310
the M1 cortex	3330
transection of their axons in the spinal cord	3350
transection	3350
their axons in the spinal cord	3365
their axons	3365
the spinal cord	3380
Our results	3397
apoptosis of primary motor cortical neurons	3423
apoptosis	3423
primary motor cortical neurons	3436
primary motor	3436
cortical neurons	3450
cortical neuronal density	3487
OEC transplantation	3532
levels of BDNF	3562
levels	3562
BDNF	3572
the OEC	3594
transplanted lesion	3602
transplantation of OECs into injured spinal cord	3629
transplantation	3629
OECs into injured spinal cord	3648
OECs	3648
injured spinal cord	3658
a neuroprotective effect on corticospinal neurons	3682
a neuroprotective effect	3682
corticospinal neurons	3710
The relative contribution of this effect to the observed functional improvement after OEC transplantation	3733
The relative contribution	3733
this effect to the observed functional improvement after OEC transplantation	3762
this effect	3762
the observed functional improvement after OEC transplantation	3777
the observed functional improvement	3777
OEC transplantation	3819
these data	3857
OEC transplantation	3882
a larger pool of surviving corticospinal neurons	3913
a larger pool	3913
surviving corticospinal neurons	3930
MATERIALS AND METHODS Isolation and Characterization of Donor OECs	3964
MATERIALS AND METHODS Isolation	3964
MATERIALS	3964
METHODS Isolation	3978
Characterization of Donor OECs	4000
Characterization	4000
Donor OECs	4020
donor OECs	4048
a procedure that relies on differential dissociation and attachment rates of subtypes of cells to serially remove other cell types and obtain a highly pure population of OECs	4079
a procedure	4079
differential dissociation and attachment rates of subtypes of cells	4106
differential dissociation and attachment rates	4106
subtypes of cells	4156
subtypes	4156
cells	4168
other cell types	4193
a highly pure population of OECs	4221
a highly pure population	4221
OECs	4249
Olfactory bulbs	4255
4	4289
8-weekold transgenic rats expressing GFP -LRB- ` Äò ` Äògreen rat ` Äô ` Äô CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb ; SLC , Shizuoka , Japan -RRB-	4295
8-weekold transgenic rats	4295
GFP -LRB- ` Äò ` Äògreen rat ` Äô ` Äô CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb ; SLC , Shizuoka , Japan -RRB-	4332
GFP	4332
Äò	4338
` Äògreen rat ` Äô ` Äô CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb ; SLC , Shizuoka , Japan	4340
` Äògreen	4340
rat ` Äô ` Äô CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb ; SLC , Shizuoka , Japan	4349
rat ` Äô ` Äô CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb	4349
rat	4349
` Äô ` Äô CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb	4352
SLC , Shizuoka , Japan	4395
SLC	4395
Shizuoka , Japan	4400
The outer nerve layer of the olfactory bulb	4418
The outer nerve layer	4418
the olfactory bulb	4443
meninges and white matter	4484
meninges	4484
white matter	4497
collagenase A and D and papain	4545
collagenase A	4545
D and papain	4563
A detailed description of OEC preparation	4577
A detailed description	4577
OEC preparation	4603
Sasaki	4635
et al. -LRB- 2004 -RRB-	4642
et al.	4642
2004	4650
The cells	4657
DMEM -LRB- 3 x 10 ^ 4 cells / ¬ µl -RRB-	4685
DMEM	4685
3 x 10 ^ 4 cells / ¬ µl	4691
3 x	4691
10 ^ 4 cells / ¬ µl	4695
10 ^	4695
4 cells / ¬ µl	4698
4 cells	4698
µl	4707
transplantation and sham injections	4718
DMEM	4769
transplantations	4799
the remaining OECs	4832
3 ` Äì7 days	4869
p75 , S-100 , and GFAP with Hoechst nuclear staining	4902
p75 , S-100 , and GFAP	4902
Hoechst nuclear staining	4928
Dorsal Funiculus Transection Experiments	4954
accordance with National Institutes of Health -LRB- NIH -RRB- Guidelines	5015
accordance	5015
National Institutes of Health -LRB- NIH -RRB- Guidelines	5031
NIH	5062
the Care and Use of Laboratory Animals	5082
the Care and Use	5082
Laboratory Animals	5102
the Yale University Institutional Animal Care and Use Committee	5126
all animal protocols	5199
A T9 dorsal transection	5221
adult female Sprague-Dawley -LRB- SD -RRB- rats -LRB- n = 46 -RRB- -LRB- 150-179 g -RRB-	5257
adult female Sprague-Dawley -LRB- SD -RRB- rats -LRB- n = 46 -RRB-	5257
adult female Sprague-Dawley -LRB- SD -RRB- rats	5257
SD	5286
n	5296
46	5300
150-179 g	5305
aseptic technique as previously described in detail -LRB- Sasaki et al. , 2004 -RRB-	5321
aseptic technique	5321
detail	5366
Sasaki	5374
et al. , 2004	5381
et al.	5381
2004	5389
OEC Transplantation	5396
transection of the dorsal funiculus	5434
transection	5434
the dorsal funiculus	5449
GFP-expressing rat OECs -LRB- n = 23 -RRB- or DMEM -LRB- n = 23 -RRB-	5471
GFP-expressing rat OECs -LRB- n = 23 -RRB-	5471
GFP-expressing rat OECs	5471
n	5496
23	5500
DMEM -LRB- n = 23 -RRB-	5507
DMEM	5507
n	5513
23	5517
the dorsal funiculus	5540
a drawn glass micropipette -LRB- Sasaki et al. , 2004 -RRB-	5567
a drawn glass micropipette	5567
Sasaki	5595
et al. , 2004	5602
et al.	5602
2004	5610
Two injections	5617
approximately 0.5 mm rostral and two at 0.5 mm caudal	5645
approximately 0.5 mm rostral	5645
two at 0.5 mm caudal	5678
the lesion at depths of 0.7	5702
the lesion	5702
depths of 0.7	5716
depths	5716
0.7	5726
0.4 mm and an additional cell injection	5734
0.4 mm	5734
an additional cell injection	5745
the transection site for a total of five injections -LRB- 1.0 ¬ µl per site ; 3.0 x 10 ^ 4 cells / ¬ µl for a total of 1.5 x 10 ^ 5 cells transplanted per rat -RRB-	5790
the transection site	5790
a total of five injections -LRB- 1.0 ¬ µl per site ; 3.0 x 10 ^ 4 cells / ¬ µl for a total of 1.5 x 10 ^ 5 cells transplanted per rat -RRB-	5815
a total	5815
five injections	5826
1.0 ¬ µl per site ; 3.0 x 10 ^ 4 cells / ¬ µl for a total of 1.5 x 10 ^ 5 cells transplanted per rat	5843
1.0 ¬ µl	5843
site ; 3.0 x 10 ^ 4 cells / ¬ µl for a total of 1.5 x 10 ^ 5 cells	5855
site	5855
3.0 x 10 ^ 4 cells / ¬ µl for a total of 1.5 x 10 ^ 5 cells	5861
3.0	5861
10 ^ 4 cells / ¬ µl for a total of 1.5 x 10 ^ 5 cells	5867
10 ^ 4 cells / ¬ µl for a total of 1.5	5867
10 ^ 4 cells / ¬ µl	5867
10 ^ 4 cells	5867
10	5867
4 cells	5870
µl	5879
a total of 1.5	5886
a total	5886
1.5	5897
10 ^ 5 cells	5903
10	5903
5 cells	5906
rat	5931
Gelfoam -LRB- Pharmacia and Upjohn , Kalamazoo , MI -RRB-	5937
Gelfoam	5937
Pharmacia and Upjohn , Kalamazoo , MI	5946
Pharmacia	5946
Upjohn , Kalamazoo , MI	5960
5 ll of Fluorogold	6000
5 ll	6000
Fluorogold	6008
FG ; 4 % w/v in saline , pH 7.4 ; Molecular Probes , Eugene , OR	6020
FG ; 4 % w/v in saline	6020
FG	6020
4 % w/v in saline	6024
4 % w/v	6024
saline	6034
pH 7.4 ; Molecular Probes	6042
pH 7.4	6042
Molecular Probes	6050
Eugene , OR	6068
Eugene	6068
OR	6076
the epicenter of the lesion cavity -LRB- Hains et al. , 2003 -RRB-	6097
the epicenter	6097
the lesion cavity -LRB- Hains et al. , 2003 -RRB-	6114
the lesion cavity	6114
Hains et al. , 2003	6133
Hains	6133
et al.	6139
2003	6147
Immunohistochemistry Procedures Animals -LRB- n = 20 -RRB-	6154
Immunohistochemistry Procedures Animals	6154
n	6195
20	6199
0.9 % saline , followed by 4 % paraformaldehyde in 0.14 M Sorensen ` Äôs buffer	6237
0.9 % saline	6237
4 % paraformaldehyde in 0.14 M Sorensen ` Äôs buffer	6262
4 % paraformaldehyde	6262
0.14 M Sorensen ` Äôs buffer	6285
0.14 M Sorensen	6285
Äôs buffer	6301
brain and spinal cord tissue	6313
brain	6313
spinal cord tissue	6323
4 ¬ ∞ C in 30 % sucrose	6374
4 ¬ ∞ C	6374
30 % sucrose	6382
Cryostat sections -LRB- 12 ¬ µm ; sagittal -RRB- of the spinal cord	6395
Cryostat sections -LRB- 12 ¬ µm ; sagittal -RRB-	6395
Cryostat sections	6395
12 ¬ µm ; sagittal	6414
12 ¬ µm	6414
sagittal	6422
the spinal cord	6435
antibodies against neurofilament -LRB- NF ; 1:1,000 ; Sigma , St. Louis , MO -RRB- , anti-monoclonal Ankyrin-G -LRB- AnkG ; 1:60 ; EMD Biosciences , San Diego , CA -RRB- , and anti-polyclonal Caspr -LRB- 1:300 , Rasband et al. , 1999 , a gift from Dr. M. Rasband , University of Connecticut Health Center , Farmington , CT -RRB-	6471
antibodies	6471
neurofilament -LRB- NF ; 1:1,000 ; Sigma , St. Louis , MO -RRB- , anti-monoclonal Ankyrin-G -LRB- AnkG ; 1:60 ; EMD Biosciences , San Diego , CA -RRB- , and anti-polyclonal Caspr -LRB- 1:300 , Rasband et al. , 1999 , a gift from Dr. M. Rasband , University of Connecticut Health Center , Farmington , CT -RRB-	6490
neurofilament -LRB- NF ; 1:1,000 ; Sigma , St. Louis , MO -RRB-	6490
neurofilament	6490
NF ; 1:1,000 ; Sigma	6505
NF	6505
1:1,000 ; Sigma	6509
1:1,000	6509
Sigma	6518
St. Louis , MO	6525
St. Louis	6525
MO	6536
anti-monoclonal Ankyrin-G -LRB- AnkG ; 1:60 ; EMD Biosciences , San Diego , CA -RRB-	6541
anti-monoclonal Ankyrin-G	6541
AnkG ; 1:60 ; EMD Biosciences	6568
AnkG	6568
1:60 ; EMD Biosciences	6574
1:60	6574
EMD Biosciences	6580
San Diego , CA	6597
San Diego	6597
CA	6608
anti-polyclonal Caspr -LRB- 1:300 , Rasband et al. , 1999 , a gift from Dr. M. Rasband , University of Connecticut Health Center , Farmington , CT -RRB-	6617
anti-polyclonal Caspr	6617
1:300 , Rasband et al. , 1999 , a gift from Dr. M. Rasband , University of Connecticut Health Center , Farmington , CT	6640
1:300 , Rasband et al.	6640
1:300	6640
Rasband et al.	6647
Rasband	6647
et al.	6655
1999 , a gift from Dr. M. Rasband	6663
1999	6663
a gift from Dr. M. Rasband	6669
a gift	6669
Dr. M. Rasband	6681
University of Connecticut Health Center , Farmington , CT	6697
University	6697
Connecticut Health Center , Farmington , CT	6711
Details of immunostaining and imaging procedures	6755
Details	6755
immunostaining and imaging procedures	6766
Sasaki	6820
et al. -LRB- 2004 -RRB-	6827
et al.	6827
2004	6835
Tunel Assay	6842
Coronal sections -LRB- 12 ¬ µm -RRB- of the brain collected at intervals of 50 ¬ µm around bregma 20.3 from animals at 1 and 4 weeks -LRB- n = 5 animals/timepoint -RRB- after surgery were examined for terminal deoxynucleotidyltransferase -LRB- TdT -RRB- - mediated deoxyuridine triphosphate -LRB- dUTP -RRB- - rhodamine nick end-labeling -LRB- TUNEL -RRB- -LRB- Roche Bioscience , Palo Alto , CA -RRB- as described previously	6854
Coronal sections -LRB- 12 ¬ µm -RRB-	6854
Coronal sections	6854
12 ¬ µm	6872
the brain collected at intervals of 50 ¬ µm around bregma 20.3 from animals at 1 and 4 weeks -LRB- n = 5 animals/timepoint -RRB-	6883
the brain	6883
intervals of 50 ¬ µm	6906
intervals	6906
50 ¬ µm	6919
bregma 20.3	6933
animals at 1 and 4 weeks -LRB- n = 5 animals/timepoint -RRB-	6950
animals	6950
1 and 4 weeks -LRB- n = 5 animals/timepoint -RRB-	6961
1 and 4 weeks	6961
n = 5 animals/timepoint	6976
n =	6976
5 animals/timepoint	6980
surgery	7007
terminal deoxynucleotidyltransferase -LRB- TdT -RRB-	7033
terminal deoxynucleotidyltransferase	7033
TdT	7071
deoxyuridine triphosphate -LRB- dUTP -RRB-	7085
deoxyuridine triphosphate	7085
dUTP	7112
rhodamine nick end-labeling -LRB- TUNEL -RRB- -LRB- Roche Bioscience , Palo Alto , CA -RRB-	7118
rhodamine nick end-labeling	7118
TUNEL	7147
Roche Bioscience	7155
Palo Alto	7173
CA	7184
Hains et al. , 2003	7213
Hains	7213
et al.	7219
2003	7227
Negative controls	7234
the absence of TdT enzyme	7270
the absence	7270
TdT enzyme	7285
a positive control	7300
some tissue	7320
DNase I -LRB- 1 ¬ µl/ml in 50 mM Tris-HCl , 10 mM MgCl2 , 1 mg/ml bovine serum albumin -LSB- BSA -RSB- -RRB-	7352
DNase I	7352
1 ¬ µl/ml in 50 mM Tris-HCl , 10 mM MgCl2 , 1 mg/ml bovine serum albumin -LSB- BSA -RSB-	7361
1 ¬ µl/ml	7361
50 mM Tris-HCl , 10 mM MgCl2 , 1 mg/ml bovine serum albumin -LSB- BSA -RSB-	7373
50 mM Tris-HCl	7373
10 mM MgCl2	7389
1 mg/ml bovine serum albumin	7402
BSA -RSB-	7432
TUNEL dUTP-fluorescein detection	7445
DNA nicks	7489
Slides	7500
Aqua-polymount -LRB- Polysciences , Warrington , PA -RRB-	7525
Aqua-polymount	7525
Polysciences	7541
Warrington	7555
PA	7567
Physical Disector Counting Method and Image Analysis Stereologic counting methods	7572
Physical Disector	7572
Method and Image Analysis Stereologic counting methods	7599
an accurate estimate of the number of FG-labeled backfilled neurons after DC lesion -LRB- n = 5 animals/timepoint , n = 20 animals total -RRB- -LRB- Smolen et al. , 1983 ; Mori et al. , 1997 ; Kwon et al. , 2002 , Hains et al. , 2003 -RRB-	7674
an accurate estimate	7674
the number of FG-labeled backfilled neurons after DC lesion -LRB- n = 5 animals/timepoint , n = 20 animals total -RRB- -LRB- Smolen et al. , 1983 ; Mori et al. , 1997 ; Kwon et al. , 2002 , Hains et al. , 2003 -RRB-	7698
the number	7698
FG-labeled backfilled neurons after DC lesion -LRB- n = 5 animals/timepoint , n = 20 animals total -RRB- -LRB- Smolen et al. , 1983 ; Mori et al. , 1997 ; Kwon et al. , 2002 , Hains et al. , 2003 -RRB-	7712
FG-labeled	7712
neurons	7734
DC lesion -LRB- n = 5 animals/timepoint , n = 20 animals total -RRB- -LRB- Smolen et al. , 1983 ; Mori et al. , 1997 ; Kwon et al. , 2002 , Hains et al. , 2003 -RRB-	7748
DC lesion -LRB- n = 5 animals/timepoint , n = 20 animals total -RRB-	7748
DC lesion	7748
n = 5 animals/timepoint , n = 20 animals total	7759
n	7759
= 5 animals/timepoint , n = 20 animals total	7761
= 5 animals/timepoint , n =	7761
5 animals/timepoint , n	7763
5 animals/timepoint	7763
n	7784
20 animals	7788
Smolen et al. , 1983 ; Mori et al. , 1997 ; Kwon et al.	7807
Smolen	7807
et al. , 1983 ; Mori et al. , 1997 ; Kwon et al.	7814
et al. , 1983	7814
et al.	7814
1983	7822
Mori et al. , 1997	7828
Mori	7828
et al. , 1997	7833
et al.	7833
1997	7841
Kwon et al.	7847
Kwon	7847
et al.	7852
2002 , Hains et al. , 2003	7860
2002	7860
Hains et al.	7866
Hains	7866
et al.	7872
2003	7880
Serial coronal sections -LRB- 20 ¬ µm -RRB-	7887
Serial coronal sections	7887
20 ¬ µm	7912
the M1 cortex	7938
every tenth section	7957
bregma 22.0 to 2.0	8010
bregma 22.0	8010
2.0	8025
Only cells that displayed prominent nuclear profiles	8030
Only cells	8030
prominent nuclear profiles	8056
The total number of FG-positive cell profiles -LRB- Ntotal -RRB-	8096
The total number of FG-positive cell profiles	8096
The total number	8096
FG-positive cell profiles	8116
Ntotal	8143
the following formula	8168
math	8192
equation	8198
section thickness t	8215
20 ¬ µm , and f = 10	8237
20 ¬ µm	8237
20 ¬	8237
µm	8241
f = 10	8249
f	8249
10	8253
The calculated distance from one disector to the next	8257
The calculated distance	8257
one disector to the next	8286
one disector	8286
the next	8302
200 ¬ µm	8315
Qi 5	8324
cell profiles	8337
the uniformly sampled disectors -LRB- crude number -RRB- ; n = 10 -LRB- number of equidistant sections used in the analysis -RRB-	8354
the uniformly sampled disectors -LRB- crude number -RRB-	8354
the uniformly sampled disectors	8354
crude number	8387
n = 10 -LRB- number of equidistant sections used in the analysis -RRB-	8402
n = 10	8402
n	8402
10	8406
number of equidistant sections used in the analysis	8410
number	8410
equidistant sections	8420
the analysis	8449
The number of cells in each of the 1 to ith-sampled sections	8464
The number	8464
cells in each of the 1 to ith-sampled sections	8478
cells	8478
each of the 1 to ith-sampled sections	8487
each	8487
the 1 to ith-sampled sections	8495
the 1	8495
ith-sampled sections	8504
the coefficient of error -LRB- Gundersen et al. , 1988 ; Abusaad et al. , 1999 -RRB-	8547
the coefficient	8547
error -LRB- Gundersen et al. , 1988 ; Abusaad et al. , 1999 -RRB-	8566
error	8566
Gundersen	8573
et al. , 1988 ; Abusaad et al. , 1999	8583
et al.	8583
1988 ; Abusaad et al.	8591
1988	8591
Abusaad et al.	8597
Abusaad	8597
et al.	8605
1999	8613
The percentage of co-positive FG and TUNEL cells	8620
The percentage	8620
co-positive FG and TUNEL cells	8638
FG and TUNEL channels	8698
three sections per animal	8724
three sections	8724
animal	8743
bregma 20.3 , where FG density was highest	8753
bregma 20.3	8753
FG density	8772
Sections 12 ¬ µm thick	8796
Sections	8796
12 ¬ µm	8805
20	8839
¬ µm sections for this analysis ; 8 - ¬ µm-thick sections	8842
¬ µm sections	8842
this analysis ; 8 - ¬ µm-thick sections	8859
this analysis	8859
8	8874
¬ µm-thick sections	8876
20 - ¬ µm disector separation	8916
20	8916
¬ µm disector separation	8919
Differences among control and experimental groups	8944
Differences	8944
control and experimental groups	8962
unpaired t-test and Wilcoxon rank-sum	9012
unpaired t-test	9012
Wilcoxon rank-sum	9032
two independent samples at a 95 % confidence interval	9054
two independent samples	9054
a 95 % confidence interval	9081
All values	9108
6 SD	9139
Open-Field Locomotor Testing Behavioral analysis	9145
the SCI1FG1 OEC group -LRB- n = 6 -RRB- and the SCI1FG1DMEM group -LRB- n = 6 -RRB-	9211
the SCI1FG1 OEC group	9211
n	9234
6	9238
the SCI1FG1DMEM group	9245
n	9268
6	9272
Preoperative testing	9276
2 days	9303
injury	9317
5 weeks	9353
surgery	9367
Locomotor function	9376
a blinded observer using the Basso , Beattie , and Bresnahan -LRB- BBB -RRB- locomotor rating scale -LRB- Basso et al. , 1995 -RRB- to ensure reliability of hind limb somatosensory testing and to assess treatment outcome	9411
a blinded observer	9411
the Basso , Beattie , and Bresnahan -LRB- BBB -RRB- locomotor rating scale -LRB- Basso et al. , 1995 -RRB-	9436
the Basso , Beattie , and Bresnahan -LRB- BBB -RRB- locomotor rating scale	9436
Basso , Beattie , and Bresnahan -LRB- BBB -RRB-	9440
Basso , Beattie , and Bresnahan	9440
Basso	9440
Beattie	9447
Bresnahan	9460
BBB	9471
Basso	9500
et al. , 1995	9506
et al.	9506
1995	9514
reliability of hind limb somatosensory testing	9530
reliability	9530
hind limb somatosensory testing	9545
treatment outcome	9591
The Mann ` ÄìWhitney U-test	9610
The Mann	9610
` ÄìWhitney U-test	9618
group comparisons for BBB analysis	9662
group comparisons	9662
BBB analysis	9684
Values	9698
¬	9725
SD	9728
ELISA Measurements	9732
1 week of survival	9754
1 week	9754
survival	9764
rats -LRB- n = 7 in each group , 2 groups , for a total of 14 animals -RRB-	9774
rats	9774
n = 7 in each group , 2 groups , for a total of 14 animals	9780
n = 7	9780
n	9780
7	9784
each group , 2 groups , for a total of 14 animals	9789
each group , 2 groups ,	9789
each group	9789
2 groups	9801
a total of 14 animals	9815
a total	9815
14 animals	9826
an overdose of pentobarbital -LRB- 75 mg/kg , i.p. -RRB-	9861
an overdose	9861
pentobarbital -LRB- 75 mg/kg , i.p. -RRB-	9876
pentobarbital	9876
75 mg/kg , i.p.	9891
75 mg/kg	9891
biochemical experiments	9927
Spinal cords	9952
30 ` Äì60 s	9987
decapitation	10003
The transplanted lesion at the T9 segment	10017
The transplanted lesion	10017
the T9 segment	10044
Tissue	10085
150 ¬ µl of ice-cold lysis buffer -LRB- 137 mM NaCl , 20 mM Tris-HCl ; pH 8.0 , 1 % Nonidet P-40 -LRB- NP-40 -RRB- , 10 % glycerol , 1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB- , 10 ¬ µg/ml aprotinin , 1 ¬ µg/ml leupeptin , and 0.5 mM sodium vanadate -RRB- , using a tube pestle -LRB- Fisher Scientific , Pittsburgh , PA -RRB-	10111
150 ¬ µl	10111
ice-cold lysis buffer -LRB- 137 mM NaCl , 20 mM Tris-HCl ; pH 8.0 , 1 % Nonidet P-40 -LRB- NP-40 -RRB- , 10 % glycerol , 1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB- , 10 ¬ µg/ml aprotinin , 1 ¬ µg/ml leupeptin , and 0.5 mM sodium vanadate -RRB-	10122
ice-cold lysis buffer	10122
137 mM NaCl , 20 mM Tris-HCl ; pH 8.0 , 1 % Nonidet P-40 -LRB- NP-40 -RRB- , 10 % glycerol , 1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB- , 10 ¬ µg/ml aprotinin , 1 ¬ µg/ml leupeptin , and 0.5 mM sodium vanadate	10145
137 mM NaCl , 20 mM Tris-HCl ; pH 8.0 , 1 % Nonidet P-40 -LRB- NP-40 -RRB- , 10 % glycerol , 1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB-	10145
137 mM NaCl , 20 mM Tris-HCl	10145
137 mM NaCl	10145
20 mM Tris-HCl	10158
pH 8.0 , 1 % Nonidet P-40 -LRB- NP-40 -RRB- , 10 % glycerol , 1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB-	10174
pH 8.0	10174
1 % Nonidet P-40 -LRB- NP-40 -RRB- , 10 % glycerol , 1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB-	10182
1 % Nonidet P-40 -LRB- NP-40 -RRB-	10182
1 % Nonidet P-40	10182
NP-40	10199
NP-40	10199
10 % glycerol	10207
1 mM phenylmethylsulfonyl fluoride -LRB- PMSF -RRB-	10221
1 mM phenylmethylsulfonyl fluoride	10221
PMSF	10257
10 ¬ µg/ml aprotinin , 1 ¬ µg/ml leupeptin	10264
10 ¬ µg/ml aprotinin	10264
1 ¬ µg/ml leupeptin	10285
0.5 mM sodium vanadate	10309
a tube pestle -LRB- Fisher Scientific , Pittsburgh , PA -RRB-	10340
a tube pestle	10340
Fisher Scientific	10355
Pittsburgh	10374
PA	10386
The sample	10391
3,000 g for 30 min	10426
3,000 g	10426
30 min	10437
4	10447
C. All	10450
C.	10450
All	10453
samples	10457
1	10482
week	10484
freezing	10495
concentrations of neurotrophic factors	10513
concentrations	10513
neurotrophic factors	10531
the spinal cord	10563
the supernatant was pooled from 7 animals in each of two groups and stored at -80 ¬ ∞ C. Samples	10580
the supernatant	10580
7 animals in each of two groups	10612
7 animals	10612
each of two groups	10625
each	10625
two groups	10633
-80 ¬	10658
-80	10658
C. Samples	10663
triplicate	10686
The supernatants	10698
NGF , NT-3 and BDNF quantification -LRB- Johnson et al. , 2000 -RRB-	10729
NGF , NT-3 and BDNF quantification	10729
Johnson	10764
et al. , 2000	10772
et al.	10772
2000	10780
The NGF E-max immunoassay system -LRB- Promega , Madison , WI -RRB-	10787
The NGF E-max immunoassay system	10787
Promega	10821
Madison	10830
WI	10839
very low crossreactivity	10856
structurally related growth factors -LSB- recombinant human BDNF -LRB- rhBDNF -RRB- , neurotrophin 3 -LRB- rhNT3 -RRB- , and neurotrophin 4 -LRB- rhNT4 -RRB-	10886
structurally related growth factors	10886
recombinant human BDNF -LRB- rhBDNF -RRB-	10923
recombinant human BDNF	10923
rhBDNF	10947
neurotrophin 3 -LRB- rhNT3 -RRB-	10956
neurotrophin 3	10956
rhNT3	10972
neurotrophin 4 -LRB- rhNT4 -RRB-	10984
neurotrophin 4	10984
rhNT4	11000
concentrations as high as 10 ng/ml	11011
concentrations	11011
high as 10 ng/ml	11029
10	11037
the manufacturer -LRB- Promega -RRB-	11063
the manufacturer	11063
Promega	11081
The BDNF E-max immunoassay system -LRB- Promega -RRB-	11091
The BDNF E-max immunoassay system	11091
Promega	11126
less than 3 % cross-reactivity	11141
NGF , NT-3 , and NT-4 at concentrations as high as 100 ng/ml	11174
NGF , NT-3 , and NT-4	11174
concentrations as high as 100 ng/ml	11197
concentrations	11197
high as 100 ng/ml	11215
100	11223
The NT-3 E-max immunoassay system -LRB- Promega -RRB-	11234
The NT-3 E-max immunoassay system	11234
Promega	11269
less than 3 % cross-reactivity	11285
related neurotrophic factors at 10 ng/ml	11318
related neurotrophic factors	11318
10 ng/ml	11350
Absorbance values of standards and samples	11360
Absorbance values	11360
standards and samples	11381
subtraction of the background value	11421
subtraction	11421
the background value	11436
absorbance due to nonspecific binding	11472
absorbance	11472
nonspecific binding	11490
The absorbance of samples	11511
The absorbance	11511
samples	11529
450 nm	11553
Values	11561
6 SEM	11588
Statistical comparisons	11595
Student	11635
Äôs t-test between the SCI1FG1OEC and the SCI1FG1DMEM groups	11643
Äôs	11643
the SCI1FG1OEC and the SCI1FG1DMEM groups	11662
the SCI1FG1OEC	11662
the SCI1FG1DMEM groups	11681
RESULTS	11706
1	11719
Sagittal frozen sections through the injury and GFP-OEC transplantation site 1 week after injury -LRB- A -RRB- .	11722
Sagittal frozen sections	11722
the injury and GFP-OEC transplantation site 1 week	11755
the injury and GFP-OEC transplantation site	11755
1 week	11799
injury -LRB- A -RRB-	11812
injury	11812
A	11820
Inset	11824
variable degrees of process outgrowth of transplanted GFP-OECs in the spinal cord	11836
variable degrees	11836
process outgrowth of transplanted GFP-OECs in the spinal cord	11856
process outgrowth	11856
transplanted GFP-OECs in the spinal cord	11877
transplanted GFP-OECs	11877
the spinal cord	11902
Four weeks	11919
transplantation -LRB- B -RRB-	11936
transplantation	11936
B	11953
transplanted cells	11957
the transplantation site	12023
a limited extent	12063
the lesion site	12087
Inset in B	12104
Inset	12104
B	12113
the presence of FG in the spinal cord	12121
the presence	12121
FG in the spinal cord	12137
FG	12137
the spinal cord	12143
C : AnkyrinG -LRB- red -RRB- and Caspr -LRB- blue -RRB- staining	12160
AnkyrinG -LRB- red -RRB- and Caspr -LRB- blue -RRB-	12163
AnkyrinG -LRB- red -RRB-	12163
AnkyrinG	12163
red	12173
Caspr -LRB- blue -RRB-	12182
Caspr	12182
nodal and paranodal regions , respectively , associated with some transplanted OECs -LRB- green -RRB-	12216
nodal and paranodal regions	12216
some transplanted OECs -LRB- green -RRB-	12275
some transplanted OECs	12275
this section	12310
34 pairs of paranodal Caspr	12324
34 pairs	12324
paranodal Caspr	12336
regions	12360
Twenty-five of the 34 - paranodal Caspr regions -LRB- 74 % -RRB- were associated with green fluorescence .	12385
Twenty-five of the 34	12385
Twenty-five	12385
the 34	12400
paranodal Caspr regions -LRB- 74 % -RRB- were associated with green fluorescence	12408
paranodal Caspr regions	12408
74 %	12433
green fluorescence	12459
Nineteen of these 25 Caspr-stained regions	12479
Nineteen	12479
these 25 Caspr-stained regions	12491
AnkG immunofluorescence at the putative nodal site	12526
AnkG immunofluorescence	12526
the putative nodal site	12553
most identified nodal ` Äì paranodal regions within the lesion	12594
most	12594
nodal ` Äì paranodal regions	12610
the lesion	12644
the transplanted OECs	12676
Inset in C	12699
Inset	12699
C	12708
NF immunostaining that reveals intimate relationship between axons and GFP expressing OECs at 4 weeks	12716
NF immunostaining	12716
intimate relationship between axons and GFP	12747
intimate relationship	12747
axons and GFP	12777
OECs	12802
4 weeks	12810
Scale bars = 500 ¬ µm in A , B ; 50 ¬ µm in inset in A ; 5 ¬ µm in C ;	12819
Scale bars	12819
500 ¬ µm in A , B ; 50 ¬ µm in inset in A ; 5 ¬ µm in C ;	12832
500 ¬ µm in A	12832
500 ¬ µm	12832
A	12843
B ; 50 ¬ µm in inset in A ; 5 ¬ µm in C ;	12846
B	12846
50 ¬ µm in inset in A ; 5 ¬ µm in C ;	12849
50 ¬ µm	12849
A ; 5 ¬ µm in C ;	12868
5 ¬ µm in C	12871
5 ¬ µm	12871
C	12880
10 ¬ µm	12883
C. Fig. 2	12902
Schematic representation -LRB- A -RRB- of a coronal atlas section of rodent brain corresponding to bregma 20.3 -LRB- Modified from Paxino and Watson , 1998 -RRB- , illustrating the location of Fluorogold -LRB- FG -RRB- - positive	12914
Schematic representation -LRB- A -RRB-	12914
Schematic representation	12914
A	12940
a coronal atlas section of rodent brain corresponding to bregma 20.3 -LRB- Modified from Paxino and Watson , 1998 -RRB- , illustrating the location of Fluorogold -LRB- FG -RRB- - positive	12946
a coronal atlas section	12946
rodent brain corresponding to bregma 20.3 -LRB- Modified from Paxino and Watson , 1998 -RRB- , illustrating the location of Fluorogold -LRB- FG -RRB- - positive	12973
rodent brain	12973
bregma 20.3	13003
Paxino and Watson , 1998	13030
Paxino	13030
Watson , 1998	13041
Watson	13041
1998	13049
the location of Fluorogold -LRB- FG -RRB- - positive	13069
the location	13069
Fluorogold -LRB- FG -RRB- - positive	13085
Fluorogold -LRB- FG -RRB-	13085
Fluorogold	13085
FG	13097
axotomized corticospinal pyramidal neurons	13121
primary motor cortex -LRB- M1 -RRB- , 1 week	13167
primary motor cortex -LRB- M1 -RRB-	13167
primary motor cortex	13167
M1	13189
1 week	13194
injury	13207
Hoechst 33342-labeled nuclei -LRB- B -RRB-	13215
Hoechst 33342-labeled nuclei	13215
B	13245
FG-positive neurons -LRB- C , inset higher magnification -RRB- within layer V. TUNEL labeling to identify neurons with DNA strand breaks -LRB- D -RRB- reveals that a fraction of FG-positive corticospinal neurons were undergoing apoptotic cell death -LRB- arrowheads -RRB-	13262
FG-positive neurons -LRB- C , inset higher magnification -RRB-	13262
FG-positive neurons	13262
C , inset higher magnification	13283
C	13283
higher magnification	13292
layer V. TUNEL labeling to identify neurons with DNA strand breaks -LRB- D -RRB- reveals that a fraction of FG-positive corticospinal neurons were undergoing apoptotic cell death -LRB- arrowheads -RRB-	13321
layer	13321
V. TUNEL labeling to identify neurons with DNA strand breaks -LRB- D -RRB-	13327
V. TUNEL labeling	13327
neurons	13357
DNA strand breaks	13370
D	13389
a fraction of FG-positive corticospinal neurons	13405
a fraction	13405
FG-positive corticospinal neurons	13419
apoptotic cell death -LRB- arrowheads -RRB-	13469
apoptotic cell death	13469
arrowheads	13491
some FGpositive neurons	13510
the TUNEL assay -LRB- arrows with tails -RRB-	13557
the TUNEL assay	13557
arrows with tails	13574
arrows	13574
tails	13586
TUNEL labeling	13594
the nuclear compartment of cells	13627
the nuclear compartment	13627
cells	13654
Scale	13661
125 ¬ µm	13673
Fig. 3 .	13683
Fig.	13683
3	13688
Hoechst 33342 , Fluorogold , and TUNEL triple labeling of corticospinal neurons 1 week after injury .	13691
Hoechst 33342	13691
Fluorogold	13706
TUNEL triple labeling of corticospinal neurons	13722
TUNEL triple labeling	13722
corticospinal neurons	13747
1 week after injury	13769
1 week	13769
injury	13782
Hoechst staining of non-TUNELpositive -LRB- arrows with tails -RRB- and TUNEL-positive -LRB- arrowheads -RRB- neurons with corresponding FG-backfilling	13790
Hoechst staining	13790
non-TUNELpositive -LRB- arrows with tails -RRB- and TUNEL-positive -LRB- arrowheads -RRB- neurons	13810
arrows with tails	13829
arrows	13829
tails	13841
arrowheads	13868
corresponding FG-backfilling	13893
SCI1FG1OEC animals -LRB- B -RRB-	13936
SCI1FG1OEC animals	13936
B	13956
fewer TUNEL-positive FG-backfilled neurons	13960
SCI1FG1DMEM -LRB- A -RRB-	14030
SCI1FG1DMEM	14030
A	14043
Insets in A show two TUNEL-positive neurons exhibiting nuclear compartmentalization and formation of nucleosomes , hallmarks of apoptosis .	14047
Insets in A show two TUNEL-positive neurons	14047
Insets	14047
A show two TUNEL-positive neurons	14057
nuclear compartmentalization and formation of nucleosomes , hallmarks of apoptosis	14102
nuclear compartmentalization and formation	14102
nucleosomes , hallmarks of apoptosis	14148
nucleosomes	14148
hallmarks of apoptosis	14161
hallmarks	14161
apoptosis	14174
Quantitation of neurons that are both TUNEL - and FG-positive -LRB- C -RRB-	14185
Quantitation	14185
neurons that are both TUNEL - and FG-positive -LRB- C -RRB-	14201
neurons	14201
both TUNEL - and FG-positive -LRB- C -RRB-	14218
both TUNEL	14218
FG-positive -LRB- C -RRB-	14234
OEC transplantation	14263
P <	14299
P	14299
<	14301
0.05	14303
apoptotic cell death at 1 week	14317
apoptotic cell death	14317
1 week	14341
No evidence of death	14349
No evidence	14349
death	14364
any other timepoint	14386
Scale bars	14407
125 ¬ µm in A , B ; 20 ¬ µm in inset in A. Fig. 4	14420
125 ¬ µm	14420
A , B ; 20 ¬ µm in inset in A. Fig. 4	14431
A	14431
B ; 20 ¬ µm in inset in A. Fig. 4	14433
B	14433
20 ¬ µm in inset in A. Fig. 4	14436
20 ¬ µm	14436
A. Fig. 4	14455
Density of FG-positive corticospinal neurons at bregma 20.3 at 1 week after axotomy	14467
Density	14467
FG-positive corticospinal neurons at bregma 20.3 at 1 week after axotomy	14478
FG-positive corticospinal neurons	14478
bregma 20.3 at 1 week after axotomy	14515
bregma	14515
20.3 at 1 week	14522
axotomy	14543
SCI1FG1OEC animals -LRB- B -RRB-	14565
SCI1FG1OEC animals	14565
B	14585
SCI1FG1DMEM animals -LRB- A -RRB-	14608
SCI1FG1DMEM animals	14608
A	14629
Serial coronal sections spanning bregma 22.0 through 2.0 from SCI1FG1DMEM and SCI1FG1OEC animals at both 1 -LRB- C -RRB- and 4 weeks -LRB- D -RRB-	14633
Serial coronal sections	14633
bregma 22.0 through 2.0	14666
bregma 22.0	14666
2.0	14686
SCI1FG1DMEM and SCI1FG1OEC animals at both 1 -LRB- C -RRB- and 4 weeks -LRB- D -RRB-	14695
SCI1FG1DMEM and SCI1FG1OEC animals at both 1 -LRB- C -RRB-	14695
SCI1FG1DMEM and SCI1FG1OEC animals	14695
both 1 -LRB- C -RRB-	14733
4 weeks -LRB- D -RRB-	14748
D	14757
SCI1FG1OEC animals -LRB- filled circles -RRB-	14774
SCI1FG1OEC animals	14774
circles	14801
FG-positive neuron density	14811
both 1 and 4 weeks	14851
SCI1FG1DMEM animals -LRB- open circles -RRB-	14890
SCI1FG1DMEM animals	14890
open circles	14911
1 to 4 weeks	14931
both groups	14945
a decrease in FG-positive backfilled neuron density	14969
a decrease	14969
FG-positive backfilled neuron density	14983
FG-positive	14983
neuron density	15006
SCI1FG1OEC animals	15026
a reduced amount of loss	15052
a reduced amount	15052
loss	15072
integral analysis	15080
Quantitation of the mean number of cells at bregma 20.3	15099
Quantitation	15099
the mean number of cells at bregma 20.3	15115
the mean number	15115
cells at bregma 20.3	15134
cells	15134
bregma 20.3	15143
OEC transplantation	15168
P <	15204
P	15204
<	15206
0.05	15208
cell loss	15225
injury -LRB- E -RRB-	15241
injury	15241
E	15249
ELISA analysis of NGF , NT-3 , and BDNF at the site of transplantation in SCI1FG1OEC and SCI1FG1DMEM animals at 1 week	15253
ELISA analysis	15253
NGF , NT-3 , and BDNF at the site of transplantation in SCI1FG1OEC and SCI1FG1DMEM animals at 1 week	15271
NGF , NT-3 , and BDNF	15271
the site of transplantation in SCI1FG1OEC and SCI1FG1DMEM animals at 1 week	15294
the site	15294
transplantation in SCI1FG1OEC and SCI1FG1DMEM animals at 1 week	15306
transplantation	15306
SCI1FG1OEC and SCI1FG1DMEM animals at 1 week	15325
SCI1FG1OEC and SCI1FG1DMEM animals	15325
1 week	15363
comparison to controls	15384
comparison	15384
controls	15398
a significant -LRB- * P < 0.05 -RRB- increase in BDNF	15408
a significant -LRB- * P < 0.05 -RRB- increase	15408
P <	15424
P	15424
<	15426
0.05	15428
BDNF	15446
no significant changes in NGF and NT - 3	15464
no significant changes	15464
NGF and NT - 3	15490
NGF and NT	15490
3	15502
F	15518
Open-field locomotor scores for SCI1FG1OEC -LRB- n = 6 -RRB- and SCI1FG1DMEM -LRB- n = 6 -RRB-	15522
Open-field locomotor scores	15522
SCI1FG1OEC -LRB- n = 6 -RRB- and SCI1FG1DMEM -LRB- n = 6 -RRB-	15554
SCI1FG1OEC	15554
n	15566
6	15570
SCI1FG1DMEM	15577
n	15590
6	15594
groups tested 1 week before and for 5 weeks after transplantation	15597
groups	15597
1 week	15611
5 weeks	15633
transplantation	15647
G	15664
All animals	15668
a gradual improvement	15690
hindlimb locomotor function	15715
the 5-week recovery period	15750
The Mann ` ÄìWhitney U-test indicated that the open-field locomotor scores at 3 , 4 , and 5 weeks after injury and SCI1FG1OEC group are significantly higher than the SCI1FG1DMEM -LRB- * P < 0.05 , ** P < 0.01 -RRB- ; Calibration in B	15778
The Mann ` ÄìWhitney U-test	15778
the open-field locomotor scores at 3 , 4 , and 5 weeks after injury and SCI1FG1OEC group	15819
the open-field locomotor scores at 3	15819
the open-field locomotor scores	15819
3	15854
4	15857
5 weeks after injury and SCI1FG1OEC group	15864
5 weeks	15864
injury and SCI1FG1OEC group	15878
the SCI1FG1DMEM -LRB- * P < 0.05 , ** P < 0.01 -RRB- ; Calibration in B	15936
the SCI1FG1DMEM -LRB- * P < 0.05 , ** P < 0.01 -RRB-	15936
the SCI1FG1DMEM	15936
P < 0.05 , ** P	15954
P	15954
< 0.05 , ** P	15956
<	15956
0.05 , ** P	15958
0.05	15958
P	15966
< 0.01	15968
<	15968
0.01	15970
Calibration in B	15977
Calibration	15977
B	15992
125 ¬ µm	16009
OECs	16032
the Spinal Cord Transection Site	16052
the cell suspensions used for transplantation	16088
the cell suspensions	16088
transplantation	16118
more than 95 % of cells	16135
more than 95 %	16135
cells	16152
p751 and S-1001	16163
The transplanted GFP-OECs	16180
the lesion zone	16236
their green fluorescence at both 1 week -LRB- Fig. 1A -RRB- and 4 weeks -LRB- Fig. 1B -RRB-	16255
their green fluorescence	16255
both 1 week -LRB- Fig. 1A -RRB- and 4 weeks -LRB- Fig. 1B -RRB-	16283
both 1 week -LRB- Fig. 1A -RRB-	16283
both 1 week	16283
Fig. 1A	16296
4 weeks -LRB- Fig. 1B -RRB-	16309
Fig. 1B	16318
transplantation	16333
1	16353
week	16355
the OECs	16361
the lesion zone	16395
variable degrees of process outgrowth -LRB- Fig. 1A , inset	16422
variable degrees of process outgrowth -LRB- Fig. 1A ,	16422
variable degrees of process outgrowth	16422
variable degrees	16422
process outgrowth	16442
Fig. 1A	16461
4 weeks	16481
the OECs	16490
the lesion zone	16529
a number of cells	16550
a number	16550
cells	16562
the lesion -LRB- Fig. 1B -RRB-	16588
the lesion	16588
Fig. 1B	16600
The inset in Figure 1B	16610
The	16610
Figure 1B	16623
the presence of FG in the spinal cord	16639
the presence	16639
FG in the spinal cord	16655
FG	16655
the spinal cord	16661
4 weeks	16681
some OECs	16690
axons as shown in the inset in Figure 1C , where OECs are seen to surround NF-stained axons	16728
axons	16728
the inset in Figure 1C , where OECs are seen to surround NF-stained axons	16746
the	16746
Figure 1C , where OECs are seen to surround NF-stained axons	16759
Figure 1C	16759
OECs	16776
NF-stained axons	16802
Immunostaining for AnkG and Caspr	16820
Immunostaining	16820
AnkG and Caspr	16839
nodal and paranodal regions -LRB- Rios et al. , 2000 -RRB- , respectively , between internodal regions formed by the transplanted OECs	16861
nodal and paranodal regions -LRB- Rios et al. , 2000 -RRB-	16861
nodal and paranodal regions	16861
Rios	16890
et al. , 2000	16895
et al.	16895
2000	16903
internodal regions formed by the transplanted OECs	16932
internodal regions	16932
the transplanted OECs	16961
Axonal alignment and nodal formation	16984
Axonal alignment	16984
nodal formation	17005
1 week post-transplantation	17041
TUNEL Staining of FG-Backfilled Cortical Neurons	17070
TUNEL Staining	17070
FG-Backfilled Cortical Neurons	17088
Apoptosis of Cortical Neurons	17125
Apoptosis	17125
Cortical Neurons	17138
1 Week	17155
Dorsal Spinal Cord Transection Bilateral transection of the dorsal corticospinal tract -LRB- dCST -RRB- and FG injection at T9	17168
Dorsal Spinal Cord Transection Bilateral transection of the dorsal corticospinal tract -LRB- dCST -RRB-	17168
Dorsal Spinal Cord	17168
Transection Bilateral transection of the dorsal corticospinal tract -LRB- dCST -RRB-	17187
Transection Bilateral transection	17187
the dorsal corticospinal tract -LRB- dCST -RRB-	17224
the dorsal corticospinal tract	17224
dCST	17256
FG injection at T9	17266
FG injection	17266
T9	17282
robust retrograde labeling of the cell bodies of these axons within the primary motor cortex -LRB- M1 -RRB- -LRB- Fig. 2C -RRB- , which spans from approximately bregma 1.6 through 21.6	17296
robust retrograde labeling	17296
the cell bodies of these axons within the primary motor cortex -LRB- M1 -RRB- -LRB- Fig. 2C -RRB-	17326
the cell bodies	17326
these axons within the primary motor cortex -LRB- M1 -RRB- -LRB- Fig. 2C -RRB-	17345
these axons	17345
the primary motor cortex -LRB- M1 -RRB- -LRB- Fig. 2C -RRB-	17364
the primary motor cortex -LRB- M1 -RRB-	17364
the primary motor cortex	17364
M1	17390
Fig. 2C	17395
approximately bregma 1.6 through 21.6	17422
approximately bregma	17422
1.6 through 21.6	17443
the coronal plane	17464
the anatomical location of labeled cells	17483
the anatomical location	17483
labeled cells	17510
a region lateral to the midline longitudinal fissure and medial to the forelimb region of the primary sensory cortex -LRB- S1 -RRB- -LRB- boxed area in Fig. 2A ; modified from Paxino and Watson , 1998 -RRB- and within cortical layer V	17535
a region	17535
the midline longitudinal fissure and medial to the forelimb region of the primary sensory cortex -LRB- S1 -RRB- -LRB- boxed area in Fig. 2A ; modified from Paxino and Watson , 1998 -RRB- and within cortical layer V	17555
the forelimb region of the primary sensory cortex -LRB- S1 -RRB- -LRB- boxed area in Fig. 2A ; modified from Paxino and Watson , 1998 -RRB-	17602
the forelimb region	17602
the primary sensory cortex -LRB- S1 -RRB- -LRB- boxed area in Fig. 2A ; modified from Paxino and Watson , 1998 -RRB-	17625
the primary sensory cortex -LRB- S1 -RRB-	17625
the primary sensory cortex	17625
S1	17653
boxed area in Fig. 2A ; modified from Paxino and Watson , 1998	17658
boxed area in Fig. 2A ; modified from Paxino	17658
boxed area	17658
Fig. 2A ; modified from Paxino	17672
Fig. 2A	17672
Paxino	17695
Watson , 1998	17706
Watson	17706
1998	17714
cortical layer	17731
the sagittal plane	17752
the anterior distribution of FGlabeled cells	17772
the anterior distribution	17772
FGlabeled cells	17801
the rostral margin of the anterior commissure	17829
the rostral margin	17829
the anterior commissure	17851
the posterior margin of the optic chiasm	17900
the posterior margin	17900
the optic chiasm	17924
cells	17950
pyramidal - shaped somata -LRB- Fig. 2C ; inset -RRB- , which give rise to a singular apical dendrite and smaller basal dendrites	17966
pyramidal - shaped somata -LRB- Fig. 2C ; inset -RRB-	17966
pyramidal	17966
shaped somata -LRB- Fig. 2C ; inset	17977
shaped somata -LRB- Fig. 2C ;	17977
shaped somata	17977
Fig. 2C	17992
Fig.	17992
2C	17997
rise	18020
a singular apical dendrite and smaller basal dendrites	18028
a singular apical dendrite	18028
smaller basal dendrites	18059
the rostrocaudal dimension	18087
the density of backfilled CST neurons	18115
the density	18115
CST neurons	18141
highest at approximately bregma 20.3	18157
highest	18157
approximately bregma 20.3	18168
approximately bregma	18168
20.3	18189
1 week after SCI	18198
1 week	18198
SCI	18211
TUNEL-positive cells	18216
layer V of M1	18258
layer V	18258
M1	18269
Hoescht 33342	18294
nuclear	18308
FG	18329
pyramidal neurons -LRB- Fig. 2B ` ÄìD , arrowheads -RRB-	18343
pyramidal neurons	18343
Fig. 2B	18362
` ÄìD , arrowheads	18369
` ÄìD	18369
arrowheads	18375
Not all FG-positive cells	18388
Fig. 2B ` ÄìD , arrows	18435
Fig. 2B	18435
` ÄìD	18442
arrows	18448
TUNEL-Positive Neurons in M1	18457
TUNEL-Positive Neurons	18457
M1	18483
OEC Transplantation Triple labeling	18504
Hoechst , FG	18545
TUNEL	18562
pyramidal cells in the SCI group	18601
pyramidal cells	18601
the SCI group	18620
spinal OEC transplantation	18652
The neuronal subset undergoing apoptosis	18680
The neuronal subset	18680
apoptosis	18711
1-week tissue	18747
these cells	18769
nuclear morphologies of both apoptotic and surrounding normal neurons and glia	18782
nuclear morphologies	18782
both apoptotic and surrounding normal neurons and glia	18806
Fig. 3A , B	18882
Fig. 3A	18882
B	18890
Hoechst staining	18894
all cells	18927
the spherical nuclear compartment	18958
a proportion of cells	18996
a proportion	18996
cells	19012
apoptosis	19029
Hoechst staining	19040
abnormal morphology	19066
the formation of chromatin condensates	19097
the formation	19097
chromatin condensates	19114
a less-distinct nucleus -LRB- Hains et al. , 2003 -RRB-	19143
a less-distinct nucleus	19143
Hains et al. , 2003	19168
Hains	19168
et al.	19174
2003	19182
Hoechst , FG	19200
TUNEL staining -LRB- Fig. 3A , B -RRB-	19217
TUNEL staining	19217
Fig. 3A , B	19233
Fig. 3A	19233
B	19241
irregular nuclear fragments identified by Hoechst staining	19256
irregular nuclear fragments	19256
Hoechst staining	19298
FGand TUNEL-positive cells	19337
the confident designation of an apoptotic status	19376
the confident designation	19376
an apoptotic status	19405
The nuclear morphology of TUNEL-positive neurons	19426
The nuclear morphology	19426
TUNEL-positive neurons	19452
that seen in our earlier paper -LRB- Hains et al. , 2003 -RRB- -LRB- Fig 3A , insets -RRB-	19492
that	19492
our earlier paper -LRB- Hains et al. , 2003 -RRB- -LRB- Fig 3A , insets -RRB-	19505
our earlier paper -LRB- Hains et al. , 2003 -RRB-	19505
our earlier paper	19505
Hains et al. , 2003	19524
Hains	19524
et al.	19530
2003	19538
Fig 3A , insets	19545
Fig 3A	19545
insets	19553
Apoptotic -LRB- FG - and TUNEL-positive cells -RRB- pyramidal neurons were observed both after SCI1FG1DMEM -LRB- Fig. 3A , arrowheads -RRB- and in the SCI1FG1OEC group -LRB- Fig. 3B , arrowheads -RRB- , but the number of apoptotic neurons	19562
Apoptotic -LRB- FG - and TUNEL-positive cells -RRB- pyramidal neurons were observed both after SCI1FG1DMEM -LRB- Fig. 3A , arrowheads -RRB- and in the SCI1FG1OEC group -LRB- Fig. 3B , arrowheads -RRB-	19562
Apoptotic	19562
- and TUNEL-positive cells -RRB-	19575
cells	19596
neurons	19613
SCI1FG1DMEM -LRB- Fig. 3A , arrowheads -RRB-	19646
SCI1FG1DMEM	19646
Fig. 3A , arrowheads	19659
Fig. 3A	19659
arrowheads	19668
the SCI1FG1OEC group -LRB- Fig. 3B , arrowheads	19687
the SCI1FG1OEC group	19687
Fig. 3B	19709
arrowheads	19718
the number of apoptotic neurons	19735
the number	19735
apoptotic neurons	19749
the SCI1FG1OEC group -LRB- Fig. 3C -RRB-	19796
the SCI1FG1OEC group	19796
Fig. 3C	19818
1	19831
week	19833
injury	19844
the number of apoptotic neurons	19852
the number	19852
apoptotic neurons	19866
P < 0.05	19903
P	19903
< 0.05	19905
<	19905
0.05	19907
45 %	19924
± 6.40 vs. 36.1 ¬	19935
± 6.40	19935
6.40	19937
36.1 ¬	19946
36.1	19946
5.69	19954
the OEC transplant group compared with the SCI1FG1DMEM group -LRB- Fig. 3C -RRB-	19963
the OEC transplant group	19963
the SCI1FG1DMEM group -LRB- Fig. 3C -RRB-	20002
the SCI1FG1DMEM group	20002
Fig. 3C	20025
4 weeks	20038
both the SCI1FG1DMEM and SCI1 FG1OEC groups	20047
the SCI1FG1DMEM	20052
SCI1 FG1OEC groups	20072
apoptotic activity comparable to sham controls -LRB- 0.98 ¬ ± 0.81 and 0.75 ¬ ± 0.56 -RRB- -LRB- Fig. 3C -RRB-	20098
apoptotic activity	20098
sham controls -LRB- 0.98 ¬ ± 0.81 and 0.75 ¬ ± 0.56 -RRB- -LRB- Fig. 3C -RRB-	20131
sham controls -LRB- 0.98 ¬ ± 0.81 and 0.75 ¬ ± 0.56 -RRB-	20131
sham controls	20131
0.98	20146
0.81 and 0.75 ¬ ± 0.56	20154
0.81 and 0.75 ¬	20154
0.81	20154
0.75 ¬	20163
0.75	20163
0.56	20171
Fig. 3C	20178
OEC Transplantation	20188
Corticospinal Neuronal Loss At 1 week after SCI , the number of FG-positive neurons was significantly -LRB- P < 0.05 -RRB- higher in the SCI1 FG1OEC transplant group	20216
Corticospinal Neuronal Loss	20216
1 week after SCI	20247
1 week	20247
SCI	20260
the number of FG-positive neurons	20265
the number	20265
FG-positive neurons	20279
P < 0.05	20318
P	20318
< 0.05	20320
<	20320
0.05	20322
the SCI1 FG1OEC transplant group	20338
Figure 4A , B	20372
Figure 4A	20372
B	20382
corresponding sections	20390
bregma 20.3 of both groups	20421
bregma 20.3	20421
both groups	20436
Quantification of the number of FG-positive neurons at 1 week -LRB- Fig. 4C -RRB- and 4 weeks -LRB- Fig. 4D -RRB- at various anteroposterior positions in M1	20449
Quantification	20449
the number of FG-positive neurons at 1 week -LRB- Fig. 4C -RRB- and 4 weeks -LRB- Fig. 4D -RRB- at various anteroposterior positions in M1	20467
the number	20467
FG-positive neurons at 1 week -LRB- Fig. 4C -RRB- and 4 weeks -LRB- Fig. 4D -RRB- at various anteroposterior positions in M1	20481
FG-positive neurons at 1 week -LRB- Fig. 4C -RRB-	20481
FG-positive neurons	20481
1 week -LRB- Fig. 4C -RRB-	20504
1 week	20504
Fig. 4C	20512
4 weeks -LRB- Fig. 4D -RRB- at various anteroposterior positions in M1	20525
4 weeks -LRB- Fig. 4D -RRB-	20525
Fig. 4D	20534
various anteroposterior positions in M1	20546
various anteroposterior positions	20546
M1	20583
increased neuronal survival at both timepoints for the SCI1FG1OEC transplant group	20596
increased neuronal survival	20596
both timepoints for the SCI1FG1OEC transplant group	20627
both timepoints	20627
the SCI1FG1OEC transplant group	20647
Stereological analysis	20680
the difference in total neuronal counts between SCI1FG1 DMEM and SCI1FG1OEC groups	20718
the difference	20718
total neuronal counts between SCI1FG1 DMEM and SCI1FG1OEC groups	20736
total neuronal counts	20736
SCI1FG1 DMEM and SCI1FG1OEC groups	20766
28.0 ¬ ± 3.76 % at 1 week , and 51.1 ¬ ± 4.58 %	20804
28.0	20804
± 3.76 % at 1 week , and 51.1 ¬	20810
± 3.76 %	20810
3.76 %	20812
1 week , and 51.1 ¬	20821
1	20821
week	20823
51.1 ¬	20833
51.1	20833
4.58 %	20841
4 weeks -LRB- Fig. 4C , D -RRB-	20850
4 weeks	20850
Fig. 4C , D	20859
Fig. 4C	20859
D	20867
This	20871
a significant difference -LRB- P < 0.05 -RRB-	20879
a significant difference	20879
P < 0.05	20905
P	20905
< 0.05	20907
<	20907
0.05	20909
neuronal loss	20931
the SCI1FG1DMEM group	20959
Definite integral area analysis	20982
loss of pyramidal neurons	21025
loss	21025
pyramidal neurons	21033
1 week to 4 weeks in the SCI1 FG1OEC	21066
1 week	21066
4 weeks in the SCI1 FG1OEC	21076
4 weeks	21076
the SCI1 FG1OEC	21087
the loss	21108
the SCI1FG1 DMEM group	21134
OEC transplantation	21158
a sparing of 24.3 ¬ ± 1.96 % and 46.3 6 3.04 % of the total number of FGpositive pyramidal cells , at 1 and 4 weeks	21185
a sparing of 24.3 ¬	21185
a sparing	21185
24.3	21198
1.96 % and 46.3 6 3.04 % of the total number of FGpositive pyramidal cells , at 1 and 4 weeks	21206
1.96 % and 46.3 6 3.04 %	21206
1.96 % and 46.3	21206
6 3.04 %	21221
the total number of FGpositive pyramidal cells , at 1 and 4 weeks	21232
the total number	21232
FGpositive pyramidal cells	21252
at 1 and 4 weeks	21280
the SCI1FG1DMEM group -LRB- Fig. 4E -RRB-	21326
the SCI1FG1DMEM group	21326
Fig. 4E	21349
This amount of sparing	21359
This amount	21359
sparing	21374
P < 0.05	21398
P	21398
< 0.05	21400
<	21400
0.05	21402
the transplant group	21411
Elevation in BDNF at the OEC Transplantation Site and Improved Locomotor Activity A number of neurotrophins	21433
Elevation	21433
BDNF at the OEC Transplantation Site and Improved Locomotor Activity A number of neurotrophins	21446
BDNF at the OEC Transplantation Site and Improved Locomotor Activity	21446
the OEC Transplantation Site	21454
Locomotor	21496
A number	21515
neurotrophins	21527
neuronal survival and axonal regeneration	21572
neuronal survival	21572
axonal regeneration	21594
SCI -LRB- Boruch et al. , 2001 ; Woodhall et al. , 2001 -RRB-	21620
SCI	21620
Boruch	21625
et al. , 2001 ; Woodhall et al. , 2001	21632
et al.	21632
2001 ; Woodhall et al.	21640
2001	21640
Woodhall et al.	21646
Woodhall	21646
et al.	21655
2001	21663
NGF , NT-3 , and BDNF	21670
NGF	21670
NT-3	21675
BDNF	21685
the injured spinal cord segments	21708
OEC transplantation	21758
BDNF	21779
the spinal segment of the OEC transplantation site	21814
the spinal segment	21814
the OEC transplantation site	21836
1 week	21865
SCI -LRB- P < 0.05 -RRB-	21878
SCI	21878
P < 0.05	21883
P	21883
< 0.05	21885
<	21885
0.05	21887
No difference	21894
NGF and NT-3 levels -LRB- Fig. 4F -RRB-	21924
NGF and NT-3 levels	21924
Fig. 4F	21945
our lesion model and transplantation protocol	21978
previous use of this model -LRB- Sasaki et al. , 2004 -RRB-	22037
previous use	22037
this model -LRB- Sasaki et al. , 2004 -RRB-	22053
this model	22053
Sasaki	22065
et al. , 2004	22072
et al.	22072
2004	22080
open-field locomotor testing -LRB- BBB -RRB-	22087
open-field locomotor testing	22087
BBB	22117
the SCI1FG1DMEM and the SCI1FG1OEC transplant groups	22141
the SCI1FG1DMEM	22141
the SCI1FG1OEC transplant groups	22161
this model system -LRB- Sasaki et al. , 2004 -RRB-	22222
this model system	22222
Sasaki	22241
et al. , 2004	22248
et al.	22248
2004	22256
OEC transplantation	22263
a significant improvement	22295
open-field locomotor activity in the OEC transplant group -LRB- Fig. 4G -RRB-	22324
open-field locomotor activity	22324
the OEC transplant group -LRB- Fig. 4G -RRB-	22357
the OEC transplant group	22357
Fig. 4G	22383
5 weeks	22396
post-transplantation BBB scores	22404
9.0 6 1.0	22441
the SCI1FG1DMEM group and 15.5 6 1.5 in the SCI1FG1OEC group -LRB- P < 0.01 -RRB-	22454
the SCI1FG1DMEM group	22454
15.5 6 1.5 in the SCI1FG1OEC group -LRB- P < 0.01 -RRB-	22480
15.5 6 1.5	22480
the SCI1FG1OEC group -LRB- P < 0.01 -RRB-	22494
the SCI1FG1OEC group	22494
P < 0.01	22516
P	22516
< 0.01	22518
<	22518
0.01	22520
DISCUSSION Corticospinal tract neurons -LRB- CST -RRB-	22528
DISCUSSION Corticospinal tract neurons	22528
DISCUSSION	22528
Corticospinal tract neurons	22539
CST	22568
apoptosis	22581
transection of their spinal axonal projections	22597
transection	22597
their spinal axonal projections	22612
1 week post-injury -LRB- Hains et al. , 2003 -RRB-	22659
1 week post-injury	22659
Hains	22679
et al. , 2003	22685
et al.	22685
2003	22693
the present study	22703
we	22721
transplantation of OECs into the dorsal transected spinal cord	22738
transplantation	22738
OECs into the dorsal transected spinal cord	22757
OECs	22757
the dorsal transected spinal cord	22767
the dorsal	22767
spinal cord	22789
apoptosis and cell death	22809
corticospinal neurons of M1	22837
corticospinal neurons	22837
M1	22862
The results	22866
a significant reduction of apoptotic M1 neurons	22890
a significant reduction	22890
apoptotic M1 neurons	22917
1 week post-transplantation and a larger number of surviving CST neurons at 4 weeks post-injury after OEC transplantation	22941
1 week post-transplantation	22941
1 week	22941
a larger number of surviving CST neurons at 4 weeks post-injury after OEC transplantation	22973
a larger number	22973
CST neurons	23002
4 weeks post-injury after OEC transplantation	23017
4 weeks post-injury	23017
OEC transplantation	23043
Our findings	23064
a larger available pool of cortical neurons	23094
a larger available pool	23094
cortical neurons	23121
OEC transplantation	23155
the spinal cord injury site	23178
a neuroprotective effect	23218
OEC transplantation on long tract	23257
OEC transplantation	23257
long tract	23280
axons	23302
We	23309
apoptotic cell death of CST neurons	23337
apoptotic cell death	23337
CST neurons	23361
transection of their axons	23379
transection	23379
their axons	23394
the spinal cord by TUNEL assay and by identification of internucleosomal DNA fragmentation -LRB- Hains et al. , 2003 -RRB-	23409
the spinal cord	23409
TUNEL assay	23428
identification of internucleosomal DNA fragmentation -LRB- Hains et al. , 2003 -RRB-	23447
identification	23447
internucleosomal DNA fragmentation -LRB- Hains et al. , 2003 -RRB-	23465
internucleosomal DNA fragmentation	23465
Hains et al. , 2003	23501
Hains	23501
et al.	23507
2003	23515
the current study	23525
the TUNEL method	23544
its high sensitivity	23577
apoptosis	23612
a variety of tissues -LRB- Gavrieli et al. , 1992 ; Migheli et al. , 1995 -RRB-	23625
a variety	23625
tissues -LRB- Gavrieli et al. , 1992 ; Migheli et al. , 1995 -RRB-	23638
tissues	23638
Gavrieli	23647
et al. , 1992 ; Migheli et al. , 1995	23656
et al.	23656
1992 ; Migheli et al.	23664
1992	23664
Migheli et al.	23670
Migheli	23670
et al.	23678
1995	23686
we	23699
the possibility of necrotic cell death of some CST neurons	23718
the possibility	23718
necrotic cell death of some CST neurons	23737
necrotic cell death	23737
some CST neurons	23760
the cell counts of FG-positive cells	23778
the cell counts	23778
FG-positive cells	23797
a preservation of axotomized CST neurons in the spinal cord after OEC transplantation	23832
a preservation	23832
CST neurons	23861
the spinal cord	23876
OEC transplantation	23898
OECs	23919
a number of neurotrophic factors , including NGF and BDNF , but not NT-3 -LRB- Boruch et al. , 2001 ; Woodhall et al. , 2001 -RRB-	23945
a number of neurotrophic factors , including NGF and BDNF	23945
a number	23945
neurotrophic factors	23957
NGF and BDNF	23989
NT-3 -LRB- Boruch et al. , 2001 ; Woodhall et al. , 2001 -RRB-	24011
NT-3	24011
Boruch	24017
et al. , 2001 ; Woodhall et al. , 2001	24024
et al.	24024
2001 ; Woodhall et al.	24032
2001	24032
Woodhall et al.	24038
Woodhall	24038
et al.	24047
2001	24055
several studies	24066
exposure to neurotrophins	24095
exposure	24095
neurotrophins	24107
death of axotomized neurons in the CNS after injury -LRB- for review see Giehl , 2001 -RRB-	24131
death	24131
axotomized neurons in the CNS after injury -LRB- for review see Giehl , 2001 -RRB-	24140
neurons	24151
the CNS	24162
injury	24176
review	24188
Giehl , 2001	24199
Giehl	24199
2001	24206
One possibility to account for the neuroprotective effect of OEC transplantation	24213
One possibility	24213
the neuroprotective effect of OEC transplantation	24244
the neuroprotective effect	24244
OEC transplantation	24274
delivery of neurotrophic factors to the injured axons by the engrafted OECs	24297
delivery	24297
neurotrophic factors to the injured axons by the engrafted OECs	24309
neurotrophic factors	24309
the injured axons by the engrafted OECs	24333
the injured axons	24333
the engrafted OECs	24354
the	24354
OECs	24368
We	24374
detectable increases	24383
BDNF	24407
NGF and NT-3 , 1 week	24424
NGF and NT-3	24424
1 week	24438
cell transplantation	24451
OECs	24489
trophic substances	24513
endogenous neurotrophic secretion	24554
Consistent with this conclusion , paracrine BDNF support	24589
Consistent	24589
this conclusion , paracrine BDNF support	24605
this conclusion	24605
paracrine BDNF support	24622
survival of CST neurons	24680
survival	24680
CST neurons	24692
proximal axotomy -LRB- Giehl and Tetzlaff , 1996 ; Schutte et al. , 2000 ; Giehl et al. , 2001 -RRB-	24710
proximal axotomy	24710
Giehl and Tetzlaff , 1996 ; Schutte et al. , 2000 ; Giehl et al. , 2001	24728
Giehl and Tetzlaff	24728
Giehl	24728
Tetzlaff	24738
1996 ; Schutte et al.	24748
1996	24748
Schutte et al.	24754
Schutte	24754
et al.	24762
2000 ; Giehl et al. , 2001	24770
2000	24770
Giehl et al. , 2001	24776
Giehl	24776
et al. , 2001	24782
et al.	24782
2001	24790
BDNF	24801
CST axons	24828
axotomy in the spinal cord -LRB- Namiki et al. , 2000 , Hiebert et al , 2002 ; Zhou and Shine , 2003 -RRB-	24844
axotomy	24844
the spinal cord -LRB- Namiki et al. , 2000 , Hiebert et al , 2002 ; Zhou and Shine , 2003 -RRB-	24855
the spinal cord	24855
Namiki	24872
et al. , 2000 , Hiebert et al , 2002 ; Zhou and Shine , 2003	24879
et al. , 2000	24879
et al.	24879
2000	24887
Hiebert et al	24893
Hiebert	24893
et al	24901
2002 ; Zhou and Shine , 2003	24908
2002	24908
Zhou and Shine , 2003	24914
Zhou and Shine	24914
2003	24930
It	24937
endogenous Schwann cells	24966
the spinal cord	25002
OEC transplantation -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB-	25024
OEC transplantation	25024
Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004	25045
Takami	25045
et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004	25052
et al. , 2002	25052
et al.	25052
2002	25060
Boyd et al. , 2004	25066
Boyd	25066
et al. , 2004	25071
et al.	25071
2004	25079
Ramer et al. , 2004	25085
Ramer	25085
et al. , 2004	25091
et al.	25091
2004	25099
changes in neurotrophic factor availabilities	25109
changes	25109
neurotrophic factor availabilities	25120
endogenous Schwann cells	25182
possible Schwann cell contamination in OEC preparations	25226
possible Schwann cell contamination	25226
OEC preparations	25265
Boyd	25306
et al. , 2005 for an overview	25311
et al.	25311
2005 for an overview	25319
2005	25319
an overview	25328
we	25348
minor contamination	25367
Schwann cells in our OEC preparation	25390
Schwann cells	25390
our OEC preparation	25407
our acute cell preparation	25428
nonexpanded cells	25467
95 % of the cells	25494
95 %	25494
the cells	25501
p751 and S-1001 -LRB- Akiyama et al. , 2004 ; Sasaki et al. , 2004 -RRB-	25515
p751 and S-1001	25515
Akiyama	25532
et al. , 2004 ; Sasaki et al. , 2004	25540
et al.	25540
2004 ; Sasaki et al.	25548
2004	25548
Sasaki et al.	25554
Sasaki	25554
et al.	25561
2004	25569
This large number of p751 and S-1001 cells from acutely dissociated outer nerve layer of the olfactory bulb , which is enriched in p751 OECs -LRB- Au et al. , 2002 -RRB- ,	25576
This large number	25576
p751 and S-1001 cells from acutely dissociated outer nerve layer of the olfactory bulb	25597
p751 and S-1001 cells	25597
outer nerve layer of the olfactory bulb	25644
outer nerve layer	25644
the olfactory bulb	25665
p751 OECs -LRB- Au et al. , 2002 -RRB-	25706
p751 OECs	25706
Au	25717
et al. , 2002	25720
et al.	25720
2002	25728
Schwann cell contamination	25750
The injured spinal cord	25800
new intraspinal circuits	25847
the rat	25875
propriospinal neurons	25884
lumbar motor neurons	25922
dorsal hemisection -LRB- Bareyre et al. , 2004 -RRB-	25949
dorsal hemisection	25949
Bareyre	25969
et al. , 2004	25977
et al.	25977
2004	25985
This new intraspinal circuit	25992
corticospinal information	26028
motor targets	26057
the lesion level	26077
One possibility to account for the improved locomotor function after OEC transplantation	26095
One possibility	26095
the improved locomotor function after OEC transplantation	26126
the improved locomotor function	26126
OEC transplantation	26164
the increased survival of corticospinal neurons by OECs	26192
the increased survival	26192
corticospinal neurons by OECs	26218
corticospinal neurons	26218
OECs	26243
enhanced intraspinal circuit construction	26261
the focus of this study	26310
the focus	26310
this study	26323
rescue of CST neurons	26341
rescue	26341
CST neurons	26351
intraspinal transplantation of OECs	26366
intraspinal transplantation	26366
OECs	26397
it	26403
neurons from other descending systems -LRB- e.g. , rubrospinal -RRB-	26423
neurons	26423
other descending systems -LRB- e.g. , rubrospinal -RRB-	26436
other descending systems	26436
e.g. , rubrospinal	26462
e.g.	26462
rubrospinal	26468
the transplantation procedure	26504
Axonal die-back	26535
CST transection that could potentially influence the survival of the parent neuron	26567
CST transection	26567
the survival of the parent neuron	26616
the survival	26616
the parent neuron	26632
We	26651
the OEC transplants	26673
axonal retraction	26702
Several groups	26721
functional recovery	26754
OEC transplantation in the injured spinal cord -LRB- Ramon-Cueto et al. , 2000 ; Plant et al. , 2003 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005 -RRB-	26780
OEC transplantation	26780
the injured spinal cord -LRB- Ramon-Cueto et al. , 2000 ; Plant et al. , 2003 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005 -RRB-	26803
the injured spinal cord	26803
Ramon-Cueto et al. , 2000 ; Plant et al. , 2003 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005	26828
Ramon-Cueto	26828
et al. , 2000 ; Plant et al. , 2003 ; Sasaki et al. , 2004 ; Garcia-Alias et al. , 2005	26840
et al. , 2000	26840
et al.	26840
2000	26848
Plant et al. , 2003	26854
Plant	26854
et al. , 2003	26860
et al.	26860
2003	26868
Sasaki et al. , 2004	26874
Sasaki	26874
et al. , 2004	26881
et al.	26881
2004	26889
Garcia-Alias et al. , 2005	26895
Garcia-Alias	26895
et al. , 2005	26908
et al.	26908
2005	26916
the precise mechanism of this functional recovery	26929
the precise mechanism	26929
this functional recovery	26954
several mechanisms including long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB- , axonal sparing -LRB- Plant et al. , 2003 -RRB- , sprouting and plasticity associated with novel polysynaptic pathways -LRB- Keyvan - Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB- , recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- and remyelination -LRB- Franklin et al. , 1996 ; Sasaki et al. , 2004 -RRB- ,	27004
several mechanisms including long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB- , axonal sparing -LRB- Plant et al. , 2003 -RRB- , sprouting and plasticity associated with novel polysynaptic pathways -LRB- Keyvan - Fouladi et al. , 2002 ; Bareyre et al. , 2004 -RRB-	27004
several mechanisms including long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB- , axonal sparing -LRB- Plant et al. , 2003 -RRB- , sprouting and plasticity associated with novel polysynaptic pathways	27004
several mechanisms	27004
long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB- , axonal sparing -LRB- Plant et al. , 2003 -RRB- , sprouting and plasticity associated with novel polysynaptic pathways	27033
long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB- , axonal sparing -LRB- Plant et al. , 2003 -RRB- , sprouting	27033
long tract regeneration -LRB- Li et al. , 1997 ; Ramon-Cueto et al. , 2000 -RRB-	27033
long tract regeneration	27033
Li	27058
et al. , 1997 ; Ramon-Cueto et al. , 2000	27061
et al.	27061
1997 ; Ramon-Cueto et al.	27069
1997	27069
Ramon-Cueto et al.	27075
Ramon-Cueto	27075
et al.	27087
2000	27095
Plant et al. , 2003	27118
Plant	27118
et al.	27124
2003	27132
plasticity associated with novel polysynaptic pathways	27153
plasticity	27153
novel polysynaptic pathways	27180
Keyvan	27209
Fouladi et al. , 2002 ; Bareyre et al. , 2004	27217
Fouladi	27217
et al. , 2002 ; Bareyre et al. , 2004	27225
et al. , 2002	27225
et al.	27225
2002	27233
Bareyre et al. , 2004	27239
Bareyre	27239
et al. , 2004	27247
et al.	27247
2004	27255
recruitment of endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- and remyelination -LRB- Franklin et al. , 1996 ; Sasaki et al. , 2004 -RRB-	27262
recruitment	27262
endogenous Schwann cells -LRB- Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB- and remyelination -LRB- Franklin et al. , 1996 ; Sasaki et al. , 2004 -RRB-	27277
endogenous Schwann cells	27277
Takami et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004	27303
Takami	27303
et al. , 2002 ; Boyd et al. , 2004 ; Ramer et al. , 2004	27310
et al. , 2002	27310
et al.	27310
2002	27318
Boyd et al. , 2004	27324
Boyd	27324
et al. , 2004	27329
et al.	27329
2004	27337
Ramer et al. , 2004	27343
Ramer	27343
et al. , 2004	27349
et al.	27349
2004	27357
remyelination	27367
Franklin	27382
et al. , 1996 ; Sasaki et al. , 2004	27391
et al.	27391
1996 ; Sasaki et al.	27399
1996	27399
Sasaki et al.	27405
Sasaki	27405
et al.	27412
2004	27420
improvement in functional outcome in SCI	27464
improvement	27464
functional outcome in SCI	27479
functional outcome	27479
SCI	27501
OEC transplantation	27511
The present study	27532
enhanced survival of CST neurons after dorsal	27563
enhanced survival	27563
CST neurons	27584
dorsal	27602
spinal cord transection and OEC transplantation	27609
spinal cord transection	27609
OEC transplantation	27637
a potentially additional role of neuroprotection	27669
a potentially additional role	27669
neuroprotection	27702
OECs on descending motor control systems	27721
OECs	27721
descending motor control systems	27729
